Healthcare provider profile · identity verified

Eric Allen, D.O.

Internal Medicine · RIVERTON, UT · NPI 1508096843

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	611	181
Amlodipine Besylate	Amlodipine Besylate	376	123
Levothyroxine Sodium	Levothyroxine Sodium	360	102
Losartan Potassium	Losartan Potassium	303	95
Lisinopril	Lisinopril	275	80
Pantoprazole Sodium	Pantoprazole Sodium	243	70
Omeprazole	Omeprazole	218	68
Gabapentin	Gabapentin	173	48
Rosuvastatin Calcium	Rosuvastatin Calcium	146	47
Metformin Hcl	Metformin Hcl	135	40
Trazodone Hcl	Trazodone Hcl	131	42
Metformin Hcl Er	Metformin Hcl	111	36
Zolpidem Tartrate	Zolpidem Tartrate	109	18
Tamsulosin Hcl	Tamsulosin Hcl	103	33
Metoprolol Succinate	Metoprolol Succinate	98	32
Potassium Chloride	Potassium Chloride	93	34
Sertraline Hcl	Sertraline Hcl	91	31
Eliquis	Apixaban	89	22
Finasteride	Finasteride	88	25
Hydrochlorothiazide	Hydrochlorothiazide	86	26
Simvastatin	Simvastatin	86	23
Carvedilol	Carvedilol	82	26
Spironolactone	Spironolactone	78	23
Trulicity	Dulaglutide	75	12
Famotidine	Famotidine	73	20
Alendronate Sodium	Alendronate Sodium	71	26
Montelukast Sodium	Montelukast Sodium	70	16
Pravastatin Sodium	Pravastatin Sodium	69	20
Furosemide	Furosemide	68	25
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	66	19
Duloxetine Hcl	Duloxetine Hcl	65	20
Fluoxetine Hcl	Fluoxetine Hcl	56	13
Clonazepam	Clonazepam	55	suppressed
Allopurinol	Allopurinol	54	17
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	54	11
Pregabalin	Pregabalin	48	11
Fluticasone Propionate	Fluticasone Propionate	47	19
Prednisone	Prednisone	47	26
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	46	suppressed
Donepezil Hcl	Donepezil Hcl	43	17
Estradiol	Estradiol	43	15
Bupropion Xl	Bupropion Hcl	42	12
Celecoxib	Celecoxib	41	15
Glipizide Er	Glipizide	41	16
Jardiance	Empagliflozin	40	suppressed
Clopidogrel	Clopidogrel Bisulfate	39	suppressed
Ozempic	Semaglutide	37	suppressed
Synthroid	Levothyroxine Sodium	37	11
Albuterol Sulfate Hfa	Albuterol Sulfate	36	19
Hydroxyzine Hcl	Hydroxyzine Hcl	34	15
Metoprolol Tartrate	Metoprolol Tartrate	34	suppressed
Symbicort	Budesonide/Formoterol Fumarate	34	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	33	19
Quetiapine Fumarate	Quetiapine Fumarate	33	suppressed
Alogliptin	Alogliptin Benzoate	32	suppressed
Mounjaro	Tirzepatide	31	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	31	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	31	suppressed
Tizanidine Hcl	Tizanidine Hcl	30	suppressed
Torsemide	Torsemide	30	suppressed
Tramadol Hcl	Tramadol Hcl	30	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	29	suppressed
Meloxicam	Meloxicam	29	suppressed
Ondansetron Hcl	Ondansetron Hcl	29	14
Alprazolam	Alprazolam	28	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	27	suppressed
Bupropion Hcl Sr	Bupropion Hcl	26	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	26	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	25	suppressed
Baclofen	Baclofen	25	suppressed
Topiramate	Topiramate	25	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	24	18
Buspirone Hcl	Buspirone Hcl	23	suppressed
Januvia	Sitagliptin Phosphate	23	suppressed
Nystatin	Nystatin	22	13
Doxycycline Monohydrate	Doxycycline Monohydrate	21	19
Oxycodone Hcl	Oxycodone Hcl	21	suppressed
Citalopram Hbr	Citalopram Hydrobromide	20	suppressed
Diazepam	Diazepam	20	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	20	suppressed
Glipizide	Glipizide	20	suppressed
Novolog Flexpen	Insulin Aspart	20	suppressed
Clonidine Hcl	Clonidine Hcl	19	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	19	suppressed
Ropinirole Hcl	Ropinirole Hcl	19	suppressed
Ipratropium Bromide	Ipratropium Bromide	18	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	18	suppressed
Nifedipine Er	Nifedipine	18	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	18	13
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	18	suppressed
Warfarin Sodium	Warfarin Sodium	18	suppressed
Atenolol	Atenolol	17	suppressed
Ezetimibe	Ezetimibe	17	suppressed
Ibuprofen	Ibuprofen	17	suppressed
Cephalexin	Cephalexin	16	11
Glimepiride	Glimepiride	16	suppressed
Armodafinil	Armodafinil	15	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	15	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	15	suppressed
Ramipril	Ramipril	15	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	15	suppressed
Valacyclovir	Valacyclovir Hcl	15	11
Doxepin Hcl	Doxepin Hcl	14	suppressed
Humalog Kwikpen U-100	Insulin Lispro	14	suppressed
Humulin N	Insulin Nph Human Isophane	14	suppressed
Lorazepam	Lorazepam	14	suppressed
Acetazolamide	Acetazolamide	13	suppressed
Aripiprazole	Aripiprazole	13	suppressed
Diltiazem 12hr Er	Diltiazem Hcl	13	suppressed
Spiriva Respimat	Tiotropium Bromide	13	suppressed
Chlorthalidone	Chlorthalidone	12	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	12	suppressed
Febuxostat	Febuxostat	12	suppressed
Lamotrigine	Lamotrigine	12	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	12	suppressed
Tolterodine Tartrate Er	Tolterodine Tartrate	12	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	12	suppressed
Xarelto	Rivaroxaban	12	suppressed
Cyanocobalamin Injection	Cyanocobalamin (Vitamin B-12)	11	suppressed
Linzess	Linaclotide	11	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	11	suppressed
Propranolol Hcl	Propranolol Hcl	11	suppressed
Risperidone	Risperidone	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error